<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: human immunodeficiency virus</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Longevity of AIDS patients presents new risks: US</title>
   	 <description> Thirty years after the AIDS epidemic first surfaced, more people than ever before in the United States -- more than 1.1 million -- are living with HIV, the Centers for Disease Control said Thursday.</description>
     <link>http://phys.org/news226256138.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 02 Jun 2011 18:40:01 EST</pubDate>
	 <guid isPermaLink="false">news226256138</guid>
	 
</item>
<item>
     <title>Some monkeys born with gene that protects against AIDS</title>
   	 <description>A certain gene in some monkeys can help boost vaccine protection against simian immunodeficiency virus (SIV), a trait that could help researchers develop better AIDS vaccines for humans, suggested a study out Wednesday.</description>
     <link>http://phys.org/news223738128.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 04 May 2011 14:29:17 EST</pubDate>
	 <guid isPermaLink="false">news223738128</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/somemonkeysb.jpg" width="90" height="90" />
</item>
<item>
     <title>Nature still sets standard for nanoscience revolution</title>
   	 <description>(PhysOrg.com) -- By striving for control and perfection in everything from computer chips to commercial jets, scientists and engineers actually exclude a fundamental force that allows nature to outperform even their best efforts.</description>
     <link>http://phys.org/news222452399.html</link>
	 <category>Nanotechnology</category>
	 <pubDate>Tue, 19 Apr 2011 17:20:23 EST</pubDate>
	 <guid isPermaLink="false">news222452399</guid>
	 
</item>
<item>
     <title>HIV-1 drug resistance mutations associated with increased risk of antiretroviral treatment failure</title>
   	 <description>An analysis of data from 10 studies indicates that the presence of low frequency (also called &quot;minority&quot;) human immunodeficiency virus type 1 (HIV-1) drug resistance mutations, particularly those involving nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance, are significantly associated with an increased risk of first-line antiretroviral treatment failure, according to an article in the April 6 issue of JAMA.</description>
     <link>http://phys.org/news221239527.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 05 Apr 2011 16:25:46 EST</pubDate>
	 <guid isPermaLink="false">news221239527</guid>
	 
</item>
<item>
     <title>After 30 years, war on AIDS at 'moment of truth'</title>
   	 <description> With the war on AIDS nearing its 30th anniversary, the UN on Thursday declared &quot;a moment of truth&quot; had come for new strategies to address the campaign's failures and brake costs that were now unsustainable.</description>
     <link>http://phys.org/news220778085.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 31 Mar 2011 08:15:06 EST</pubDate>
	 <guid isPermaLink="false">news220778085</guid>
	 
</item>
<item>
     <title>HIV integration requires use of a host DNA-repair pathway</title>
   	 <description>The human immunodeficiency virus (HIV), the cause of AIDS, makes use of the base excision repair pathway when inserting its DNA into the host-cell genome, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center &amp;#150; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Crippling the repair pathway prevents the virus from completing this critical step in the retrovirus's life cycle.</description>
     <link>http://phys.org/news220263624.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 25 Mar 2011 09:40:03 EST</pubDate>
	 <guid isPermaLink="false">news220263624</guid>
	 
</item>
<item>
     <title>Pushing HIV out the door: How host factors aid in the release of HIV particles</title>
   	 <description>Human Immunodeficiency Virus (HIV) &amp;#150; which causes AIDS &amp;#150; invades human immune cells and causes them to produce new copies of the virus, which can then infect new cells. A research team led by Professor Don C. Lamb (Ludwig-Maximilians-Universit&amp;#228;t in Munich) and Priv.-Doz. Dr. Barbara M&amp;#252;ller of Heidelberg University Hospital have now analyzed the involvement of particular components of the infected cell in virion release, and discovered that the enzyme VPS4A plays a more active role in the process than was previously thought. VPS4A was already known to act after virus budding was complete. Using an advanced microscopy technique, the group was able to show that complexes containing about a dozen VPS4A molecules form at points in the membrane at which newly assembled virions later emerge.</description>
     <link>http://phys.org/news219058742.html</link>
	 <category>Biology</category>
	 <pubDate>Fri, 11 Mar 2011 09:39:26 EST</pubDate>
	 <guid isPermaLink="false">news219058742</guid>
	 
</item>
<item>
     <title>ATS issues report on emerging issues in HIV-associated pulmonary disease</title>
   	 <description>The American Thoracic Society has released a new report detailing recent global changes in the management of human immunodeficiency virus (HIV)-associated pulmonary disease. The report examines the evolving landscape of HIV and its associated diseases in areas where combination antiretroviral therapies (ART) are available, as well as offering insight into the trends occurring in areas of the world where ART use is limited.</description>
     <link>http://phys.org/news218385621.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 03 Mar 2011 14:50:01 EST</pubDate>
	 <guid isPermaLink="false">news218385621</guid>
	 
</item>
<item>
     <title>HIV makes protein that may help virus's resurgence</title>
   	 <description>New research enhances the current knowledge of how human immunodeficiency virus type-1 (HIV-1), which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.</description>
     <link>http://phys.org/news217854064.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 25 Feb 2011 11:01:39 EST</pubDate>
	 <guid isPermaLink="false">news217854064</guid>
	 
</item>
<item>
     <title>Patients infected with HIV have higher drop-out rate for liver transplantation</title>
   	 <description>French researchers determined that infection with human immunodeficiency virus (HIV) impaired results of transplant surgery for liver cancer, with more HIV infected patients dropping off the transplantation wait list. The team found that overall survival and recurrence-free survival was not impacted following liver transplantation in patients with controlled HIV disease. Details of this single center study&amp;#151;the largest to date&amp;#151;are published in the February issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news215175928.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 25 Jan 2011 11:20:01 EST</pubDate>
	 <guid isPermaLink="false">news215175928</guid>
	 
</item>
<item>
     <title>Stroke rate rises for patients with HIV infection</title>
   	 <description>While the overall hospitalization rate for stroke has declined in recent years, the numbers have  jumped dramatically for patients infected with human immunodeficiency virus (HIV), suggesting they may be up to three times more likely to suffer a stroke than people uninfected by the virus that causes AIDS.</description>
     <link>http://phys.org/news214682789.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 19 Jan 2011 18:06:53 EST</pubDate>
	 <guid isPermaLink="false">news214682789</guid>
	 
</item>
<item>
     <title>Scientists reveal complete structure of HIV's outer shell</title>
   	 <description>A team of scientists at The Scripps Research Institute and the University of Virginia has determined the structure of the protein package that delivers the genetic material of the human immunodeficiency virus (HIV) to human cells.</description>
     <link>http://phys.org/news214665704.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 19 Jan 2011 13:22:13 EST</pubDate>
	 <guid isPermaLink="false">news214665704</guid>
	 
</item>
<item>
     <title>New look at multitalented protein sheds light on mysteries of HIV</title>
   	 <description>New insights into the human immunodeficiency virus (HIV) infection process, which leads to acquired immunodeficiency syndrome (AIDS), may now be possible through a research method recently developed in part at the National Institute of Standards and Technology, where scientists have glimpsed an important protein molecule's behavior with unprecedented clarity.</description>
     <link>http://phys.org/news206279398.html</link>
	 <category>Chemistry</category>
	 <pubDate>Thu, 14 Oct 2010 13:00:01 EST</pubDate>
	 <guid isPermaLink="false">news206279398</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/newlookatmul.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists reveal first structure of a class of proteins that help guide blood cell movement</title>
   	 <description>Researchers have determined the structure of a protein that helps guide blood-forming stem cells, or hematopoetic stem cells. The protein is also one of the main receptors used by the human immunodeficiency virus (HIV) to get inside blood cells.</description>
     <link>http://phys.org/news205679979.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 07 Oct 2010 14:19:58 EST</pubDate>
	 <guid isPermaLink="false">news205679979</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/studydetails.jpg" width="90" height="90" />
</item>
<item>
     <title>Hepatitis C virus faces new weapon</title>
   	 <description>In recent human trials for a promising new class of drug designed to target the hepatitis C virus (HCV) without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.</description>
     <link>http://phys.org/news204982969.html</link>
	 <category>Chemistry</category>
	 <pubDate>Wed, 29 Sep 2010 12:43:02 EST</pubDate>
	 <guid isPermaLink="false">news204982969</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/1-hepatitiscvi.jpg" width="90" height="90" />
</item>
<item>
     <title>Prototype vaginal gel fails to block HIV: study</title>
   	 <description> A vaginal gel failed to protect women against the AIDS virus, doctors said on Monday, reporting on a major clinical trial that enrolled more than 9,000 women.</description>
     <link>http://phys.org/news204178749.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Sep 2010 05:19:28 EST</pubDate>
	 <guid isPermaLink="false">news204178749</guid>
	 
</item>
<item>
     <title>Israeli researchers develop promising new HIV treatment</title>
   	 <description> Israeli researchers have developed a new treatment for HIV that kills human cells infected with the virus and could lead to a breakthrough in treating AIDS, the Haaretz newspaper said on Friday.</description>
     <link>http://phys.org/news202722295.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 03 Sep 2010 08:45:23 EST</pubDate>
	 <guid isPermaLink="false">news202722295</guid>
	 
</item>
<item>
     <title>Researchers pave the way for a better understanding of HIV infection and AIDS</title>
   	 <description>Dr. Eric A. Cohen, Director of the Human Retrovirology research unit at the Institut de recherches cliniques de Montreal (IRCM), and his team published yesterday, in the online open-access journal PLos Pathogens, the results of their most recent research on the role of the Vpr protein in HIV (human immunodeficiency virus) infection and AIDS (acquired immune deficiency syndrome).</description>
     <link>http://phys.org/news202667118.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 02 Sep 2010 17:26:55 EST</pubDate>
	 <guid isPermaLink="false">news202667118</guid>
	 
</item>
<item>
     <title>HIV virus hides in the brain</title>
   	 <description>Studies of the spinal fluid of patients given anti-HIV drugs have resulted in new findings suggesting that the brain can act as a hiding place for the HIV virus. Around 10% of patients showed traces of the virus in their spinal fluid but not in their blood -- a larger proportion than previously realised, reveals a thesis from the University of Gothenburg, Sweden.</description>
     <link>http://phys.org/news201776810.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 23 Aug 2010 10:20:06 EST</pubDate>
	 <guid isPermaLink="false">news201776810</guid>
	 
</item>
<item>
     <title>Vanishing bile duct syndrome secondary to anti-retroviral therapy in HIV</title>
   	 <description>Vanishing bile duct syndrome (VBDS) is an important cause of jaundice, and results from destruction of bile ducts in the liver. However, this syndrome is rare in patients with human immunodeficiency virus infection. Nevirapine, an anti-retroviral that is being increasingly used, was implicated as the cause of VBDS in a patient described in a recent report.</description>
     <link>http://phys.org/news199706046.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 30 Jul 2010 12:00:07 EST</pubDate>
	 <guid isPermaLink="false">news199706046</guid>
	 
</item>
<item>
     <title>Is there a cure for AIDS? Forum lifts a taboo</title>
   	 <description> Scientists at the world AIDS conference have discussed an idea that had become almost taboo. Can AIDS be cured?</description>
     <link>http://phys.org/news198930130.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 21 Jul 2010 11:50:01 EST</pubDate>
	 <guid isPermaLink="false">news198930130</guid>
	 
</item>
<item>
     <title>World AIDS conference opens to demo, call for funds</title>
   	 <description> The 18th International AIDS Conference opened here on Sunday to UN pleas and activists' clamour for countries not to backtrack in the 29-year war on acquired immune deficiency syndrome.</description>
     <link>http://phys.org/news198685952.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 18 Jul 2010 15:32:50 EST</pubDate>
	 <guid isPermaLink="false">news198685952</guid>
	 
</item>
<item>
     <title>Drugs, microbicide gel, money top issues at AIDS meet</title>
   	 <description> A global AIDS forum was getting underway here on Sunday, with major announcements expected over six days on the drugs that have turned HIV from killer to a chronic but manageable disease, and the quest for a virus-thwarting gel.</description>
     <link>http://phys.org/news198653761.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 18 Jul 2010 07:00:01 EST</pubDate>
	 <guid isPermaLink="false">news198653761</guid>
	 
</item>
<item>
     <title>HIV vaccines may induce HIV antibodies in trial participants, can cause false-positive test result</title>
   	 <description>During trials of preventive HIV vaccines, trial participants may develop HIV-related antibody responses that could lead to a positive HIV test by routine antibody detection methods (called vaccine-induced seropositivity/reactivity [VISP]), and the potential for false-positive test results and an incorrect HIV diagnosis, according to a study in the July 21 issue of JAMA, a theme issue on HIV/AIDS.</description>
     <link>http://phys.org/news198573121.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 18 Jul 2010 04:00:21 EST</pubDate>
	 <guid isPermaLink="false">news198573121</guid>
	 
</item>
<item>
     <title>Half of HIV-exposed babies in parts of Africa not receiving available HIV prevention</title>
   	 <description>In the ongoing battle to prevent mother-to-child transmission of human immunodeficiency virus (HIV), not all weapons are being used: Only about half of HIV-exposed infants in some African countries received a minimal dose of the prevention drug nevirapine, say researchers at the University of Alabama at Birmingham.</description>
     <link>http://phys.org/news198573008.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 18 Jul 2010 04:00:01 EST</pubDate>
	 <guid isPermaLink="false">news198573008</guid>
	 
</item>
<item>
     <title>Stem-cell work closes a door to AIDS virus</title>
   	 <description> Lab work on mice has opened up a novel way of closing a gateway to the AIDS virus, according to a study published on Friday.</description>
     <link>http://phys.org/news197303523.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 02 Jul 2010 15:32:26 EST</pubDate>
	 <guid isPermaLink="false">news197303523</guid>
	 
</item>
<item>
     <title>HIV patients with lymphoma given new hope</title>
   	 <description>(PhysOrg.com) -- The Human Immunodeficiency Virus (HIV) is widely treated using highly active antiretroviral therapy (HAART), which patients must continue throughout their lives. Now a new study suggests the patients’ own stem cells could be genetically modified and then transplanted back into their bodies to give them a single administration therapy, given once and lasting for life. This could avoid the costs and the toxic side effects of the traditional HAART.</description>
     <link>http://phys.org/news196061539.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 18 Jun 2010 06:32:36 EST</pubDate>
	 <guid isPermaLink="false">news196061539</guid>
	 
</item>
<item>
     <title>AIDS drugs given to pregnant women block 99 percent of HIV transmission to breastfed babies</title>
   	 <description>An international clinical trial led by researchers at the Harvard School of Public Health (HSPH) has found that AIDS-fighting antiretroviral drug combinations given to pregnant and breastfeeding women in Botswana, Africa, prevented 99% of the mothers from transmitting the human immunodeficiency virus (HIV) to their infants.</description>
     <link>http://phys.org/news195911630.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 16 Jun 2010 17:10:05 EST</pubDate>
	 <guid isPermaLink="false">news195911630</guid>
	 
</item>
<item>
     <title>HIV-positive women are less likely to find work than men affected by the virus</title>
   	 <description>Juan Oliva, a researcher at the University of Castilla-La Mancha (UCLM) explores the relationship between the employment status of Human Immunodeficiency Virus (HIV)-positive individuals and socioeconomic characteristics in Spain between 2001 and 2004. The study finds that gender is a &quot;statistically significant&quot; variable when predicting employment status.</description>
     <link>http://phys.org/news192105247.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 May 2010 11:50:13 EST</pubDate>
	 <guid isPermaLink="false">news192105247</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/hivpositivew.jpg" width="90" height="90" />
</item>
<item>
     <title>Preventing HPV might lower risk of HIV infection in men: study</title>
   	 <description>(PhysOrg.com) -- Men infected with human papillomavirus (HPV) are at greater risk of becoming infected with human immunodeficiency virus (HIV) than men who are not HPV positive, according to researchers at the University of North Carolina at Chapel Hill.</description>
     <link>http://phys.org/news191685809.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 28 Apr 2010 15:40:01 EST</pubDate>
	 <guid isPermaLink="false">news191685809</guid>
	 
</item>


</channel>
</rss>
